l-carnitine deficiency in infants Lessons From a Case Study of an Infant With Primary Carnitine Frontiers | Newborn Screening and

Treatment response should be tracked with redox proteomics (cysteine-switch/oxidized-PTP signatures), peroxiredoxin redox states (as sentinels of H 2 O 2 flux) and lipid-peroxide markers (F 2 -isoprostanes, oxidized phospholipids), enabling adaptive dosing that preserves beneficial redox signalling in normal tissues while exploiting malignant redox liabilities (Kisty et al

It is seronegative, meaning unlike rheumatoid arthritis, it does not produce a positive rheumatoid factor on blood testing

View Abstract Novel human oncogene lbc detected by transfection with distinct homology regions to signal transduction products

Evaluation of sphingolipid metabolism in renal cortex of rats with streptozotocin-induced diabetes and the effects of rapamycin